Swiss Re AG (VTX:SREN) has been given a consensus recommendation of “Buy” by the twelve analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is CHF 105.05.
SREN has been the subject of a number of recent research reports. Deutsche Bank set a CHF 108 target price on Swiss Re and gave the stock a “neutral” rating in a research report on Wednesday, July 31st. Barclays reaffirmed a “buy” rating on shares of Swiss Re in a research note on Wednesday, September 11th. Goldman Sachs Group set a CHF 110 price target on Swiss Re and gave the stock a “buy” rating in a research note on Wednesday, October 2nd. JPMorgan Chase & Co. set a CHF 118 price target on Swiss Re and gave the stock a “buy” rating in a research note on Monday, September 16th. Finally, DZ Bank reaffirmed a “buy” rating on shares of Swiss Re in a research note on Tuesday, September 10th.
Swiss Re has a 52-week low of CHF 81.65 and a 52-week high of CHF 98.80.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Featured Article: What is the significance of a dead cat bounce?
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.